Rutin Attenuates Vancomycin-Induced Nephrotoxicity By Ameliorating Oxidative Stress, Apoptosis, And Inflammation In Rats

Shaoqi Qu,Cunchun Dai,Fengting Lang,Longfei Hu,Qihe Tang,Haixia Wang,Yanping Zhang,Zhihui Hao
DOI: https://doi.org/10.1128/AAC.01545-18
IF: 5.938
2019-01-01
Antimicrobial Agents and Chemotherapy
Abstract:Nephrotoxicity is the major limiting factor for the clinical use of vancomycin (VCM) for treatment of serious infections caused by multiresistant Grampositive bacteria. This study investigated the renal protective activity of rutin in a rat model of VCM-induced kidney injury in male Wistar rats. VCM administered intraperitoneally at 200 mg/kg twice daily for 7 successive days resulted in significant elevation of blood urea nitrogen and creatinine, as well as urinary N-acetyl-beta-D-glucosaminidase. Coadministration of VCM with oral rutin at 150 mg/kg significantly reduced these markers of kidney damage. Rutin also significantly attenuated VCM-induced oxidative stress, inflammatory cell infiltration, apoptosis, and decreased interleukin-1 beta and tumor necrosis factor alpha levels (all P < 0.05 or 0.01) in kidneys. Renal recovery from VCM injury was achieved by rutin through increases in Nrf2 and HO-1 and a decrease in NF-kappa B expression. Our results demonstrated a protective effect of rutin on VCM-induced kidney injury through suppression of oxidative stress, apoptosis, and downregulation of the inflammatory response. This study highlights a role for oral rutin as an effective intervention to ameliorate nephrotoxicity in patients undergoing VCM therapy.
What problem does this paper attempt to address?